Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center.

@article{NicolatouGalitis2011OsteonecrosisOT,
  title={Osteonecrosis of the jaw in oncology patients treated with bisphosphonates: prospective experience of a dental oncology referral center.},
  author={Ourania Nicolatou-Galitis and Erofili Papadopoulou and Triantafyllia Sarri and Polyxeni Boziari and Aikaterini Karayianni and Marie-Christine Kyrtsonis and Panagiotis Repousis and Vassilios Barbounis and C{\'e}sar Augusto Migliorati},
  journal={Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics},
  year={2011},
  volume={112 2},
  pages={195-202}
}
OBJECTIVES The objectives of this study were to define the incidence, pain, and healing in cancer patients treated with intravenous bisphosphonates. STUDY DESIGN The study included long-term follow-up of 99 bisphosphonate-using patients (group A) and conservative treatment of 67 patients with bisphosphonate-related osteonecrosis of the jaw (BRONJ, group B) using 3 antibiotic schemes and oral hygiene. RESULTS The frequency of zoledronic acid single-agent use was 85.9% and 69.8% in group A… CONTINUE READING